• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荧光染料 1-苯胺萘-8-磺酸与过氧化物酶体增殖物激活受体 γ 的选择性结合允许配体的鉴定和表征。

Selective binding of the fluorescent dye 1-anilinonaphthalene-8-sulfonic acid to peroxisome proliferator-activated receptor gamma allows ligand identification and characterization.

机构信息

Instituto de Química-Física Rocasolano, Consejo Superior de Investigaciones Científicas, E-28006 Madrid, Spain.

出版信息

Anal Biochem. 2010 Apr 1;399(1):84-92. doi: 10.1016/j.ab.2009.12.021. Epub 2009 Dec 16.

DOI:10.1016/j.ab.2009.12.021
PMID:20025845
Abstract

Peroxisome proliferator-activated receptor gamma (PPARgamma) is a member of the nuclear receptor superfamily involved in insulin sensitization, atherosclerosis, inflammation, and carcinogenesis. PPARgamma transcriptional activity is modulated by specific ligands that promote conformational changes allowing interaction with coactivators. Here we show that the fluorophore 1-anilinonaphthalene-8-sulfonic acid (ANS) binds to PPARgamma-LBD (ligand binding domain), displaying negligible interaction with other nuclear receptors such as PPARalpha and retinoid X receptor alpha (RXRalpha). ANS binding is competed by PPARgamma agonists such as rosiglitazone, 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)), and 9,10-dihydro-15-deoxy-Delta(12,14)-prostaglandin J(2) (CAY10410). Moreover, the affinity of PPARgamma for these ligands, determined through ANS competition titrations, is within the range of that reported previously, thereby suggesting that ANS competition could be useful in the screening and characterization of novel PPARgamma agonists. In contrast, gel-based competition assays showed limited performance with noncovalently bound ligands. We applied the ANS binding assay to characterize a biotinylated analog of 15d-PGJ(2) that does not activate PPAR in cells. We found that although this compound bound to PPARgamma with low affinity, it failed to promote PPARgamma interaction with a fluorescent SRC-1 peptide, indicating a lack of receptor activation. Therefore, combined approaches using ANS and fluorescent coactivator peptides to monitor PPARgamma binding and interactions may provide valuable strategies to fully understand the role of PPARgamma ligands.

摘要

过氧化物酶体增殖物激活受体 γ(PPARγ)是核受体超家族的一员,参与胰岛素敏感性、动脉粥样硬化、炎症和癌变。PPARγ 的转录活性受特定配体的调节,这些配体促进构象变化,允许与共激活因子相互作用。在这里,我们表明荧光染料 1-苯胺萘-8-磺酸(ANS)与 PPARγ-LBD(配体结合域)结合,与其他核受体如 PPARα 和视黄酸 X 受体 α(RXRα)几乎没有相互作用。ANS 结合被 PPARγ 激动剂如罗格列酮、15-脱氧-Δ(12,14)-前列腺素 J2(15d-PGJ2)和 9,10-二氢-15-脱氧-Δ(12,14)-前列腺素 J2(CAY10410)竞争。此外,通过 ANS 竞争滴定法测定的 PPARγ 对这些配体的亲和力在先前报道的范围内,这表明 ANS 竞争可能有助于新型 PPARγ 激动剂的筛选和表征。相比之下,基于凝胶的竞争测定法显示出与非共价结合的配体的性能有限。我们应用 ANS 结合测定法来表征一种生物素化的 15d-PGJ2 类似物,该类似物在细胞中不激活 PPAR。我们发现,尽管该化合物与 PPARγ 的亲和力较低,但它未能促进 PPARγ 与荧光 SRC-1 肽的相互作用,表明受体未被激活。因此,使用 ANS 和荧光共激活因子肽结合和相互作用监测 PPARγ 的组合方法可能为充分理解 PPARγ 配体的作用提供有价值的策略。

相似文献

1
Selective binding of the fluorescent dye 1-anilinonaphthalene-8-sulfonic acid to peroxisome proliferator-activated receptor gamma allows ligand identification and characterization.荧光染料 1-苯胺萘-8-磺酸与过氧化物酶体增殖物激活受体 γ 的选择性结合允许配体的鉴定和表征。
Anal Biochem. 2010 Apr 1;399(1):84-92. doi: 10.1016/j.ab.2009.12.021. Epub 2009 Dec 16.
2
Combined biophysical and cell-based approaches for the assessment of ligand binding to PPARγ.
Methods Mol Biol. 2013;952:237-52. doi: 10.1007/978-1-62703-155-4_18.
3
Atomic structure of mutant PPARgamma LBD complexed with 15d-PGJ2: novel modulation mechanism of PPARgamma/RXRalpha function by covalently bound ligands.与15d - PGJ2复合的突变型PPARγ配体结合域的原子结构:共价结合配体对PPARγ/RXRα功能的新型调节机制
FEBS Lett. 2009 Jan 22;583(2):320-4. doi: 10.1016/j.febslet.2008.12.017. Epub 2008 Dec 26.
4
Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.通过与内源性脂肪酸的共价修饰对过氧化物酶体增殖物激活受体γ(PPARγ)激活的结构洞察。
J Mol Biol. 2009 Jan 9;385(1):188-99. doi: 10.1016/j.jmb.2008.10.039. Epub 2008 Oct 19.
5
Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation.鉴定 15d-PGJ2 为法尼醇 X 受体拮抗剂:结合生物学评价的分子模拟。
Steroids. 2013 Sep;78(9):813-22. doi: 10.1016/j.steroids.2013.04.018. Epub 2013 May 23.
6
Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.过氧化物酶体增殖物激活受体γ配体通过不同的过氧化物酶体增殖物激活受体γ依赖性机制刺激内皮细胞一氧化氮生成。
Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1810-6. doi: 10.1161/01.ATV.0000177805.65864.d4. Epub 2005 Jul 14.
7
Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists.过氧化物酶体增殖物激活受体γ(PPARγ)配体在近端肾小管细胞中的差异效应:噻唑烷二酮类是部分PPARγ激动剂。
Kidney Int. 2004 Jun;65(6):2081-90. doi: 10.1111/j.1523-1755.2004.00624.x.
8
Development of a novel PPARγ ligand screening system using pinpoint fluorescence-probed protein.利用精准荧光探针蛋白开发新型过氧化物酶体增殖物激活受体γ(PPARγ)配体筛选系统
Biosci Biotechnol Biochem. 2011;75(2):337-41. doi: 10.1271/bbb.100810. Epub 2011 Feb 7.
9
A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.一种使用荧光素标记的双过氧化物酶体增殖物激活受体α/γ激活剂的快速、均相荧光偏振结合测定法,用于检测过氧化物酶体增殖物激活受体α和γ。
Anal Biochem. 2007 Apr 15;363(2):263-74. doi: 10.1016/j.ab.2007.01.022. Epub 2007 Jan 28.
10
A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist.一种基于酵母双杂交技术的用于发现过氧化物酶体增殖物激活受体γ(PPARγ)激动剂和拮抗剂的系统。
Anal Biochem. 2004 Dec 15;335(2):253-9. doi: 10.1016/j.ab.2004.09.004.

引用本文的文献

1
Lipoxidation and cancer immunity.脂质氧化与癌症免疫。
Redox Biol. 2019 May;23:101103. doi: 10.1016/j.redox.2019.101103. Epub 2019 Jan 11.
2
Cellular and Biophysical Pipeline for the Screening of Peroxisome Proliferator-Activated Receptor Beta/Delta Agonists: Avoiding False Positives.用于筛选过氧化物酶体增殖物激活受体β/δ激动剂的细胞和生物物理流程:避免假阳性
PPAR Res. 2018 Apr 12;2018:3681590. doi: 10.1155/2018/3681590. eCollection 2018.
3
Screening for PPAR Non-Agonist Ligands Followed by Characterization of a Hit, AM-879, with Additional No-Adipogenic and cdk5-Mediated Phosphorylation Inhibition Properties.
筛选过氧化物酶体增殖物激活受体(PPAR)非激动剂配体,随后对一种活性化合物AM-879进行表征,该化合物具有额外的非脂肪生成和细胞周期蛋白依赖性激酶5(cdk5)介导的磷酸化抑制特性。
Front Endocrinol (Lausanne). 2018 Feb 1;9:11. doi: 10.3389/fendo.2018.00011. eCollection 2018.
4
Detoxifying Enzymes at the Cross-Roads of Inflammation, Oxidative Stress, and Drug Hypersensitivity: Role of Glutathione Transferase P1-1 and Aldose Reductase.处于炎症、氧化应激和药物超敏反应交叉点的解毒酶:谷胱甘肽转移酶P1-1和醛糖还原酶的作用
Front Pharmacol. 2016 Aug 4;7:237. doi: 10.3389/fphar.2016.00237. eCollection 2016.
5
Study of protein haptenation by amoxicillin through the use of a biotinylated antibiotic.通过使用生物素化抗生素研究阿莫西林的蛋白质半抗原化。
PLoS One. 2014 Mar 3;9(3):e90891. doi: 10.1371/journal.pone.0090891. eCollection 2014.